PALI (Palisade Bio) Other Current Liabilities: $0.12 Mil (As of Mar. 2026)


PALI Palisade Bio Inc PALI
35 GF Score
Price $2.08
! 2 Warning Signs
View Full Analysis

What is Palisade Bio Other Current Liabilities?

Palisade Bio PALI +1.71% 35 Other Current Liabilities is $0.12 Mil as of Mar. 2026. GuruFocus rates PALI with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

Palisade Bio's other current liabilities for the quarter that ended in Mar. 2026 was $0.12 Mil.

Palisade Bio's quarterly other current liabilities increased from Sep. 2025 ($0.62 Mil) to Dec. 2025 ($1.61 Mil) but then declined from Dec. 2025 ($1.61 Mil) to Mar. 2026 ($0.12 Mil).

Palisade Bio's annual other current liabilities declined from Dec. 2023 ($0.91 Mil) to Dec. 2024 ($0.72 Mil) but then increased from Dec. 2024 ($0.72 Mil) to Dec. 2025 ($1.61 Mil).

Palisade Bio Other Current Liabilities Related Terms

Palisade Bio Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Palisade Bio's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Palisade Bio Other Current Liabilities Chart

Palisade Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 0.51 0.67 0.91 0.72 1.61

Palisade Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.19 0.62 1.61 0.12
PALI
35GF Score
Palisade Bio Inc PALI
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Palisade Bio Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.12 Mil mean?
Palisade Bio (PALI) has a Other Current Liabilities of $0.12 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Palisade Bio.
Is Palisade Bio's Other Current Liabilities too high?
Palisade Bio's current Other Current Liabilities is $0.12 Mil. Overall, Palisade Bio has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Palisade Bio's Other Current Liabilities compare to IRD and GALT?
Palisade Bio's Other Current Liabilities of $0.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Palisade Bio. Palisade Bio's current Other Current Liabilities is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Palisade Bio stock overvalued right now?
Palisade Bio (PALI) has a current Other Current Liabilities of $0.12 Mil. The current Other Current Liabilities is $0.12 Mil. Palisade Bio's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Palisade Bio (PALI), the current Other Current Liabilities is $0.12 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Palisade Bio Business Description

Address 4600 South Syracuse Street, Suite 900, Denver, CO, USA, 80237
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
35GF Score

Get the complete analysis for PALI

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.08
Price